Trending Now
Brickell Biotech Inc. (NASDAQ:BBI) Announce dosing of First Patent In Cardigan...
Brickell Biotech Inc. (NASDAQ:BBI) has dosed the first patient in the second US vital Phase 3 clinical trials ("Cardigan II study"). The...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
G1 Therapeutics Inc. (NASDAQ:GTHX) Revises Its 2020 Guidance And Announces Q3...
G1 Therapeutics Inc. (NASDAQ:GTHX) has announced its Q3 2020 financial results and corporate updates for the period ended September 30, 2020. The company ended...
MAKE IT MODERN
LATEST REVIEWS
Actinium Pharmaceuticals Inc. (ATNM) Leads Breakthroughs in Targeted Radiotherapy with Iomab-B...
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in targeted radiotherapies, continues to make significant strides in revolutionizing cancer treatment.
MAKE IT MODERN
PERFORMANCE TRAINING
Tapping Recession-Proof Stocks to Fight the Bear (SNPS, KEGS, SAM, ABT, NEE, HD, ACN,...
Fed Chair Jay Powell took a trip to Capitol Hill this week for his regular interrogation by Congress – no doubt a...
INOVIO Pharmaceuticals (NASDAQ:INO) Partners With IVI To Commence COVID-19 Vaccine Clinical Trials In South...
INOVIO Pharmaceuticals (NASDAQ:INO), Seoul National University Hospital, and International Vaccine Institute (IVI) have announced a partnership to commence Phase 1/2 clinical study COVID-19 INO-4800...
IGM Biosciences, Inc. (IGMS): Significant Stock Surge Following Positive First-Quarter Results
IGM Biosciences, Inc. (NASDAQ: IGMS) recently saw a substantial increase in its stock price, closing at $11.47, up by 36.39% during regular...
Virpax Pharmaceutical Inc. (NASDAQ: VRPX) Enters Supply and Manufacturing Agreement For MMS019
Virpax Pharmaceutical Inc. (NASDAQ: VRPX) and Seqens have announced the signing of a commercial supply and manufacturing agreement for MMS019.
Virpax and Seqens enter a...
Beam Therapeutics Inc. (NASDAQ: BEAM) Announce Q2 2021 Financial Results And Progress of BEAM-201...
Beam Therapeutics Inc. (NASDAQ: BEAM) has announced its recent pipeline, business updates, and Q2 2021 financial results.
Beam started IND-enabling studies on BEAM-201
The company initiated...
MAKE IT MODERN
